Molecular basis of Alzheimer's may differ among patients, study suggests

09/13/2013 | MedicalXpress.com

U.S. researchers who cultivated beta-amyloid fibrils using tissue from the brains of two Alzheimer's patients with distinct levels of brain damage and medical histories found the protein from each patient had different molecular structures. The findings could lead to the development of personalized diagnostic and treatment strategies, researchers reported in the journal Cell.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT